Cargando…

Strain-specific metastatic phenotypes in pheochromocytoma allograft mice

Somatostatin receptor-targeting endoradiotherapy offers potential for treating metastatic pheochromocytomas and paragangliomas, an approach likely to benefit from combination radiosensitization therapy. To provide reliable preclinical in vivo models of metastatic disease, this study characterized th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ullrich, Martin, Liers, Josephine, Peitzsch, Mirko, Feldmann, Anja, Bergmann, Ralf, Sommer, Ulrich, Richter, Susan, Bornstein, Stefan R, Bachmann, Michael, Eisenhofer, Graeme, Ziegler, Christian G, Pietzsch, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176113/ https://www.ncbi.nlm.nih.gov/pubmed/30288966 http://dx.doi.org/10.1530/ERC-18-0136

Ejemplares similares

Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model
por: Ullrich, Martin, et al.
Publicado: (2016)

Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells
por: Bechmann, Nicole, et al.
Publicado: (2019)

Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models
por: Ullrich, Martin, et al.
Publicado: (2023)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
por: Nölting, Svenja, et al.
Publicado: (2019)

Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background
por: Ullrich, Martin, et al.
Publicado: (2019)

HIF2alpha-Associated Pseudohypoxia Promotes Radioresistance in Pheochromocytoma: Insights from 3D Models
por: Seifert, Verena, et al.
Publicado: (2021)

Anti-Tumorigenic and Anti-Metastatic Activity of the Sponge-Derived Marine Drugs Aeroplysinin-1 and Isofistularin-3 against Pheochromocytoma In Vitro
por: Bechmann, Nicole, et al.
Publicado: (2018)

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses
por: Fischer, Alessa, et al.
Publicado: (2023)

Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome
por: Ziegler, Christian G., et al.
Publicado: (2022)

Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion
por: Li, Minghao, et al.
Publicado: (2021)

Update on Modern Management of Pheochromocytoma and Paraganglioma
por: Lenders, Jacques W. M., et al.
Publicado: (2017)

Differential Responses of Urinary Epinephrine and Norepinephrine to 24-h Shift-Work Stressor in Physicians
por: Boettcher, Claudia, et al.
Publicado: (2020)

Preclinical Characterization of the (177)Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5
por: Striese, Franziska, et al.
Publicado: (2023)

Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells
por: Brandt, Florian, et al.
Publicado: (2022)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma
por: Rao, Dipti, et al.
Publicado: (2017)

Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
por: Constantinescu, Georgiana, et al.
Publicado: (2022)

Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
por: Constantinescu, Georgiana, et al.
Publicado: (2020)

Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model
por: Helm, Jana, et al.
Publicado: (2022)

Adrenal Hormone Interactions and Metabolism: A Single Sample Multi-Omics Approach
por: Bechmann, Nicole, et al.
Publicado: (2021)

From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
por: Albert, Susann, et al.
Publicado: (2018)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
por: Richter, Susan, et al.
Publicado: (2018)

Compensation for chronic oxidative stress in ALADIN null mice
por: Jühlen, Ramona, et al.
Publicado: (2018)

Long-Term Excessive Dietary Phosphate Intake Increases Arterial Blood Pressure, Activates the Renin–Angiotensin–Aldosterone System, and Stimulates Sympathetic Tone in Mice
por: Latic, Nejla, et al.
Publicado: (2022)

Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma
por: Maison, Nicole, et al.
Publicado: (2016)

SUN-222 Pre- and Post-Pubertal Reference Ranges for Oxygenated Androgens in Saliva
por: Adaway, Joanne, et al.
Publicado: (2020)

Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status
por: Eisenhofer, Graeme, et al.
Publicado: (2017)

Reduced pulmonary blood flow in regions of injury 2 hours after acid aspiration in rats
por: Richter, Torsten, et al.
Publicado: (2015)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
por: Calsina, Bruna, et al.
Publicado: (2023)

Development of a ghrelin receptor inverse agonist for positron emission tomography
por: Bergmann, Ralf, et al.
Publicado: (2021)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

Targeted Quantification of Carbon Metabolites Identifies Metabolic Progression Markers and an Undiagnosed Case of SDH-Deficient Clear Cell Renal Cell Carcinoma in a German Cohort
por: William, Doreen, et al.
Publicado: (2021)

Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development
por: Mohr, Hermine, et al.
Publicado: (2021)

Optimized procedures for testing plasma metanephrines in patients on hemodialysis
por: Pamporaki, Christina, et al.
Publicado: (2021)

Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
por: Mitwasi, Nicola, et al.
Publicado: (2017)

An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment
por: Huebner, Doreen, et al.
Publicado: (2017)

Spine Stereotactic Radiosurgery for Metastatic Pheochromocytoma
por: Mesko, Shane, et al.
Publicado: (2019)

Mutational Profile of Metastatic Pheochromocytoma and Paraganglioma
por: Choi, Yun Mi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2l9hq224mo5nlhkhvbmrvsgkpa